These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 17130121)

  • 41. Dehydrocostuslactone suppresses angiogenesis in vitro and in vivo through inhibition of Akt/GSK-3β and mTOR signaling pathways.
    Wang CY; Tsai AC; Peng CY; Chang YL; Lee KH; Teng CM; Pan SL
    PLoS One; 2012; 7(2):e31195. PubMed ID: 22359572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin-like growth factor-1 suppresses the Myostatin signaling pathway during myogenic differentiation.
    Retamales A; Zuloaga R; Valenzuela CA; Gallardo-Escarate C; Molina A; Valdés JA
    Biochem Biophys Res Commun; 2015 Aug; 464(2):596-602. PubMed ID: 26151859
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PI-3K/Akt/GSK-3beta signaling cascades stimulated by insulin like growth factor-I contribute to multiple myeloma cells proliferation and survival.
    Wang MC; Fu XD; Li MX
    Chin Med J (Engl); 2006 Jul; 119(14):1226-9. PubMed ID: 16863618
    [No Abstract]   [Full Text] [Related]  

  • 44. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
    Dong J; Peng J; Zhang H; Mondesire WH; Jian W; Mills GB; Hung MC; Meric-Bernstam F
    Cancer Res; 2005 Mar; 65(5):1961-72. PubMed ID: 15753396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells.
    Shin HS; Lee HJ; Nishida M; Lee MS; Tamura R; Yamashita S; Matsuzawa Y; Lee IK; Koh GY
    Circ Res; 2003 Aug; 93(4):302-10. PubMed ID: 12869389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action.
    Yakes FM; Chinratanalab W; Ritter CA; King W; Seelig S; Arteaga CL
    Cancer Res; 2002 Jul; 62(14):4132-41. PubMed ID: 12124352
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase.
    Dufourny B; Alblas J; van Teeffelen HA; van Schaik FM; van der Burg B; Steenbergh PH; Sussenbach JS
    J Biol Chem; 1997 Dec; 272(49):31163-71. PubMed ID: 9388270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
    Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
    J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A potential mechanism for fumonisin B(1)-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3beta activity.
    Ramljak D; Calvert RJ; Wiesenfeld PW; Diwan BA; Catipovic B; Marasas WF; Victor TC; Anderson LM; Gelderblom WC
    Carcinogenesis; 2000 Aug; 21(8):1537-46. PubMed ID: 10910956
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Opposing extracellular signal-regulated kinase and Akt pathways control Schwann cell myelination.
    Ogata T; Iijima S; Hoshikawa S; Miura T; Yamamoto S; Oda H; Nakamura K; Tanaka S
    J Neurosci; 2004 Jul; 24(30):6724-32. PubMed ID: 15282275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.
    Wang Y; Lam JB; Lam KS; Liu J; Lam MC; Hoo RL; Wu D; Cooper GJ; Xu A
    Cancer Res; 2006 Dec; 66(23):11462-70. PubMed ID: 17145894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.
    Horn S; Endl E; Fehse B; Weck MM; Mayr GW; Jücker M
    Leukemia; 2004 Nov; 18(11):1839-49. PubMed ID: 15457186
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclin G1-mediated epithelial-mesenchymal transition via phosphoinositide 3-kinase/Akt signaling facilitates liver cancer progression.
    Wen W; Ding J; Sun W; Fu J; Chen Y; Wu K; Ning B; Han T; Huang L; Chen C; Xie D; Li Z; Feng G; Wu M; Xie W; Wang H
    Hepatology; 2012 Jun; 55(6):1787-98. PubMed ID: 22271581
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
    Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
    Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
    Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
    Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of PRIP, a phosphatidylinositol 4,5-bisphosphate binding protein, attenuates PI3K/AKT signaling and suppresses tumor growth in a xenograft mouse model.
    Maetani Y; Asano S; Mizokami A; Yamawaki Y; Sano T; Hirata M; Irifune M; Kanematsu T
    Biochem Biophys Res Commun; 2021 May; 552():106-113. PubMed ID: 33743346
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CREB participates in the IGF-I-stimulation cyclin D1 transcription.
    Yan Y; Li X; Kover K; Clements M; Ye P
    Dev Neurobiol; 2013 Aug; 73(8):559-70. PubMed ID: 23447091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of cyclin D1 expression by autocrine IGF-I in human BON neuroendocrine tumour cells.
    von Wichert G; Haeussler U; Greten FR; Kliche S; Dralle H; Böhm BO; Adler G; Seufferlein T
    Oncogene; 2005 Feb; 24(7):1284-9. PubMed ID: 15580291
    [TBL] [Abstract][Full Text] [Related]  

  • 59. c-Fos overexpression increases the proliferation of human hepatocytes by stabilizing nuclear Cyclin D1.
    Güller M; Toualbi-Abed K; Legrand A; Michel L; Mauviel A; Bernuau D; Daniel F
    World J Gastroenterol; 2008 Nov; 14(41):6339-46. PubMed ID: 19009649
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts.
    Conejo R; Lorenzo M
    J Cell Physiol; 2001 Apr; 187(1):96-108. PubMed ID: 11241354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.